The story of Viagra and its parent , copyright, presents a complex picture for cautious investors. While the blockbuster drug initially produced enormous earnings, its exclusivity has lapsed , leading to generic versions flooding the market . This decline in pricing presents a substantial obstacle for copyright and any company considering a heavy p